Minglu Tang
12 Papers
Minglu Tang is an academic researcher. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 6, co-authored 7 publications.
Chat about Author
Papers
Dual active nanozyme-loaded MXene enables hyperthermia-enhanced tumor nanocatalytic therapy
Minglu Tang,Yangtian Shi,Liang Lu,Jingqi Li,Zhao Zhang,Jiatong Ni,Wenxin Wang,Yanhua Zhang,Tiedong Sun,Zhiguang Wu +9 more
TL;DR: In this paper , a dual active nanozyme-loaded MXene-integrated nanozyme that exhibits dual catalytic activities, exerting synergistic effects to enhance tumor therapy was presented.
47
Manganese‐Based Nanozymes: Preparation, Catalytic Mechanisms, and Biomedical Applications
TL;DR: In this review, the typical preparation strategies, catalytic mechanisms, advances and perspectives of Mn-based nanozymes for biomedical applications are systematically summarized and the application of Mn -based nanoZymes in tumor therapy and sensing detection, together with an overview of their mechanism of action is highlighted.
45
Polyoxometalate-Nanozyme-Integrated Nanomotors (POMotors) for Self-Propulsion-Promoted Synergistic Photothermal-Catalytic Tumor Therapy.
Minglu Tang,Jiatong Ni,Zhengya Yue,Chun-sheng Chen,Xing Ma,Lei Wang +5 more
- 20 Dec 2023
TL;DR: This approach overcomes the disadvantages of the intrinsic fragile nature of enzyme-powered nanomotors in physiological environments, and more importantly, providing a motility-behavior promoted synergistic anti-tumor strategy.
35
Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy.
Jialun Li,Zhengya Yue,Minglu Tang,Wenxin Wang,Yuan Sun,Tiedong Sun,Chun-sheng Chen +6 more
TL;DR: This review provides an overview of various approaches developed to alleviate hypoxia and improve the efficiency of SDT, and highlights the future prospects and challenges of the hypoxia‐alleviated SDT, along with the key considerations for future clinical applications.
31
Polyoxometalate-covalent organic framework hybrid materials for pH-responsive photothermal tumor therapy.
Wenxin Wang,Yuting Song,Jiayi Chen,Yanyan Yang,Jiawei Wang,Yan Song,Jiatong Ni,Minglu Tang,Jun Wei Zhao,Yuan Sun,Tiedong Sun,Jinsong Peng +11 more
TL;DR: The resultant HPB@COF platform exhibited desirable biocompatibility, pH-responsive release properties and high tumor inhibition efficiency, which can be used for PTT to effectively inhibit tumor growth.
27